For adult patients with type 2 diabetes, treated with diet and exercise
REALIZE THE POTENTIAL WITH OZEMPIC®
Choose Ozempic® as your preferred first injectable—the only once-weekly GLP-1 RA therapy with superior results vs Trulicity®2
Pen shown delivers doses of 0.25 mg or 0.5 mg.
CKD=chronic kidney disease; CVD=cardiovascular disease; CVOT=cardiovascular outcomes trial; GLP-1 RA=glucagon-like peptide-1 receptor agonist; T2D=type 2 diabetes.
bThe primary composite endpoint was the time from randomization to first occurrence of a MACE: CV death, nonfatal myocardial infarction, or nonfatal stroke.
cResults apply to Ozempic® plus standard of care vs standard of care alone in SUSTAIN 6 trial.